- Investing Ideas
- /
- U.S. Biotech Stocks
U.S. Biotech Stocks
Results
510
0 new
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
510 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
LLY | US$786.23 | -1.4% | 33.5% | US$731.0b | US$991.89 | PE84.6x | E29.5% | 0.7% | ||
JNJ | US$151.87 | -3.1% | 1.2% | US$368.9b | US$174.62 | PE24.8x | E10.3% | 3.3% | ||
ABBV | US$169.63 | -15.4% | 22.7% | US$301.0b | US$205.62 | PE59x | E27.7% | 3.9% | ||
MRK | US$98.36 | -2.8% | -3.6% | US$249.2b | US$131.72 | PE20.5x | E15.5% | 3.1% | ||
TMO | US$533.02 | -4.1% | 12.8% | US$207.3b | US$656.23 | PE33.2x | E11.8% | 0.3% | ||
PFE | US$26.02 | -5.2% | -12.6% | US$151.4b | US$32.88 | PE34.5x | E16.8% | 6.5% | ||
VRTX | US$483.96 | -3.7% | 41.1% | US$127.4b | US$513.87 | PS11.7x | E47.2% | n/a | ||
BMY | US$58.50 | 6.9% | 15.1% | US$118.5b | US$58.64 | PS2.5x | E48.7% | 4.1% | ||
GILD | US$92.11 | -5.9% | 23.6% | US$115.4b | US$94.62 | PE911.1x | E40.7% | 3.3% | ||
REGN | US$782.51 | -5.1% | -1.8% | US$86.5b | US$1,082.63 | PE18.1x | E8.1% | n/a | ||
ZTS | US$174.63 | 0.2% | -1.1% | US$79.9b | US$214.78 | PE32.4x | E9.9% | 1.0% | ||
A | US$130.22 | -6.7% | 14.0% | US$38.6b | US$150.11 | PE26.5x | E4.1% | 0.7% | ||
ALNY | US$257.91 | -5.3% | 52.6% | US$34.1b | US$301.40 | PS15.9x | E70.7% | n/a | ||
BNTX | US$103.56 | -4.0% | 3.9% | US$26.7b | US$131.88 | PS7.8x | E11.7% | n/a | ||
HZNP | US$116.30 | 0.06% | 82.8% | US$26.6b | US$116.50 | PE60.8x | E16.4% | n/a | ||
MTD | US$1,237.78 | -12.3% | 17.9% | US$26.6b | US$1,331.68 | PE32.8x | E7.8% | n/a | ||
BIIB | US$164.89 | -5.2% | -28.1% | US$24.2b | US$252.11 | PE14.9x | E13.6% | n/a | ||
ILMN | US$142.24 | -8.3% | 49.4% | US$23.2b | US$164.20 | PS5.1x | E70.4% | 2.2% | ||
WAT | US$376.72 | -2.4% | 41.5% | US$22.9b | US$375.45 | PE35.9x | E8.6% | n/a | ||
BGNE | US$193.29 | -6.5% | 2.2% | US$20.8b | US$277.11 | PS6.3x | E71.9% | n/a | ||
TEVA | US$16.75 | -4.3% | 91.2% | US$19.2b | US$22.36 | PS1.1x | E65.8% | 0% | ||
UTHR | US$386.27 | -4.0% | 70.4% | US$17.9b | US$382.29 | PE15.5x | E8.1% | n/a | ||
ICLR | US$200.02 | -7.0% | -25.7% | US$16.8b | US$283.00 | PE22.1x | E13.7% | n/a | ||
MRNA | US$39.77 | -20.9% | -48.0% | US$16.2b | US$85.05 | PS3x | E18.4% | n/a |